What\'s new in COPD?
Journal Title: Przewodnik Lekarza - Year 2006, Vol 84, Issue 2
Abstract
Results of clinical studies conducted in patients with chronic obstructive pulmonary disease (COPD) in recent years have pointed out at new perspectives in the management of COPD. They include both pharmacological and non-pharmacological methods. Progress in pharmacological therapy results mainly due to introduction of long acting anticholinergic compound and combined therapy with long acting β2-agonists and inhaled corticosteroids. Non-invasive positive pressure ventilation (NIPPV) appears to play a significant role in the treatment of severe COPD exacerbations. Also pulmonary rehabilitation has found very important position in the management of COPD patients. However, from patients’ perspective the most important benefit resulting from new therapies is an improvement in health related quality of live.
Authors and Affiliations
Paweł Śliwiński
Keywords
Related Articles
- EP ID EP101976
- DOI -
- Views 77
- Downloads 0
Headache in the general practitioner\'s office
The author presents the clinical symptomatology, pathogenesis, diagnosis and therapy regarding the common forms of the primary (idiopathic) and secondary (symptomatic) headaches. The migraine, tension type headache, cl...
Ochrona przed powikłaniami
Nowe dane z Brigham and Women’s Hospital przedstawione na Kongresie Europejskiego Towarzystwa Kardiologicznego w 2005 r. dowodzą, że rozpoczęcie podawania klopidogrelu przed interwencją wieńcową pozwala na uniknięcie po...
Natural history and treatment of Type 2 diabetes mellitus
The pathogenesis of type 2 diabetes mellitus involves abnormalities in insulin action, insulin secretion and endogenous glucose output. However, the sequence of phenomena leading to the development and progression of abn...
Pain management in rheumatic diseases
There are two kinds of pain in rheumatic diseases: nociceptive and non nociceptive (neurophatic, psychogenic pain). Nociceptive pain is due to inflammatory process not only in rheumatoid arthritis and inflammatory spon...
Inhibitory konwertazy angiotensyny i antagoniści receptora dla angiotensyny w nefropatii cukrzycowej
Nefropatia cukrzycowa jest wiodącą przyczyną prowadzącą do schyłkowej niewydolności nerek. W dużych prospektywnych badaniach klinicznych udowodniono, że intensywne postępowanie w cukrzycy opóźnia wystąpienie mikroalbumin...